Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00123175
Status:
WITHDRAWN
Last Update Posted:
2013-01-08
First Post:
2005-07-20
Brief Title:
Treatment of Endometrial Hyperplasia With an Intrauterine Device IUD
Sponsor:
Milton S Hershey Medical Center
Organization:
Milton S Hershey Medical Center
Study Overview
Official Title:
Levonorgestrel Containing Intrauterine Device in the Treatment of Endometrial Hyperplasia Without Atypia
Status:
WITHDRAWN
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study has never received funding and has never been initiated
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to determine the effectiveness of the intrauterine device IUD called Mirena when compared to the Provera tablets used in treating this condition
Detailed Description:
Endometrial hyperplasia without atypia is a condition usually caused by excessive stimulation of the uterine lining endometrium by estrogens and may cause irregular bleeding as a presenting symptom but rarely may progress to endometrial cancer which makes treatment important The only treatment approved so far is medroxyprogesterone acetate tablets progesterone also known as Provera
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None